rs1021737
From SNPedia
| Orientation | plus |
| Stabilized | plus |
| Geno | Mag | Summary |
|---|---|---|
| (G;G) | 0 | common in clinvar |
| (T;T) | 3 | significantly higher plasma total homocysteine concentration |
| Make rs1021737(G;T) |
| Reference | GRCh38 38.1/141 |
| Chromosome | 1 |
| Position | 70439117 |
| Gene | CTH |
| is a | snp |
| is | mentioned by |
| dbSNP | rs1021737 |
| dbSNP (classic) | rs1021737 |
| ClinGen | rs1021737 |
| ebi | rs1021737 |
| HLI | rs1021737 |
| Exac | rs1021737 |
| Gnomad | rs1021737 |
| Varsome | rs1021737 |
| LitVar | rs1021737 |
| Map | rs1021737 |
| PheGenI | rs1021737 |
| Biobank | rs1021737 |
| 1000 genomes | rs1021737 |
| hgdp | rs1021737 |
| ensembl | rs1021737 |
| geneview | rs1021737 |
| scholar | rs1021737 |
| rs1021737 | |
| pharmgkb | rs1021737 |
| gwascentral | rs1021737 |
| openSNP | rs1021737 |
| 23andMe | rs1021737 |
| SNPshot | rs1021737 |
| SNPdbe | rs1021737 |
| MSV3d | rs1021737 |
| GWAS Ctlg | rs1021737 |
| Merged from | Rs17407754 |
| GMAF | 0.2259 |
| Max Magnitude | 3 |
| ? | (G;G) (G;T) (T;T) | 28 |
|---|---|---|
|
| ||
| ClinVar | |
|---|---|
| Risk | Rs1021737(T;T) |
| Alt | Rs1021737(T;T) |
| Reference | Rs1021737(G;G) |
| Significance | Other |
| Disease | Homocysteine Cystathioninuria |
| Variation | info |
| Gene | CTH |
| CLNDBN | Homocysteine, total plasma, elevated Cystathioninuria |
| Reversed | 0 |
| HGVS | NC_000001.10:g.70904800G>T |
| CLNSRC | OMIM Allelic Variant UniProtKB (protein) |
| CLNACC | RCV000003075.4, RCV000331590.1, |
[PMID 18701025] Relationship between cystathionine gamma-lyase gene polymorphism and essential hypertension in Northern Chinese Han population.
[PMID 19048631
] Oral facial clefts and gene polymorphisms in metabolism of folate/one-carbon and vitamin A: a pathway-wide association study.
[PMID 25807836] The importance of rs1021737 and rs482843 polymorphisms of cystathionine gamma-lyase in the etiology of preeclampsia in the Caucasian population
[PMID 29694444
] One-carbon metabolism biomarkers and genetic variants in relation to colorectal cancer risk by KRAS and BRAF mutation status.
